A study that will research the efficacy of aminocaproic acid and conjugated estrogens as treatments for the prevention of exercise-induced pulmonary hemorrhage (EIPH) in horses has been selected to receive a one-year, $75,000 grant.
Several sale company officials have written a letter to Dr. Larry Bramlage complaining about how an American Association of Equine Practitioners task force handled the development and release to the public of its guidelines for medications in sale horses.
The American Association of Equine Practitioners' Task Force on Medication Issues at Public Auction has released its recommendations for medication usage in horses presented for sale at public auctions.
The AAEP Foundation, Inc. has donated $50,000 to aid Gulf Coast horses affected by Hurricane Katrina. Donations of $25,000 each have been made to the Louisiana Veterinary Medical Association and the Mississippi Veterinary Medical Association.
Equine veterinarians representing the American Association of Equine Practitioners' "On Call" program will assist NBC Sports with horse health information during the Oct. 29 Breeders' Cup World Thoroughbred Championships at Belmont Park.
The equine industry's work on behalf of unwanted horses continued to gain momentum Sept. 21 when representatives from 20 organizations met to advance efforts that began at the nation's first Unwanted Horse Summit in Washington, D.C. in April.
A second Unwanted Horse Summit has been scheduled for Sept. 21, and in the interim, a steering committee will consider ways to formally structure the endeavor.
A follow-up report on the April 19 Unwanted Horse Summit in Washington, D.C., lists "action steps," including development of an organization structure to address the controversial issue.
The first Unwanted Horse Summit was called a success, though participants acknowledged devising ways to deal with tens of thousands of horses a year would take cooperation and compromise from all segments of the equine industry.
More than 20 equine organizations have committed to send at least one representative to the first "Unwanted Horse Summit" scheduled for April 19 as part of the American Horse Council meeting in Washington, D.C.
With the premiere of the 2005 Citgo Racing to the Kentucky Derby Series March 5, the American Association of Equine Practitioners' "On Call" program will mark its 15th year of providing media assistance to live network Thoroughbred races.
It's been pretty quiet since the Sales Integrity Task Force released its code of ethics for public Thoroughbred auctions late last year. But that will change beginning with the Fasig-Tipton Florida select sale of 2-year-olds in training on Tuesday at Calder Race Course, according to WinStar Farm co-owner Bill Casner, who heads a committee formed to publicize the code of ethics.
The American Association of Equine Practitioners, in an effort to educate members, has issued guidelines for the responsible use of compounded medications by veterinarians.
The American Association of Equine Practitioners has announced plans to host an Unwanted Horse Summit. The summit, a one-day conference bringing equine industry leaders together to address the problem of unwanted horses, will take place Tuesday, April 19, 2005, during the American Horse Council's annual meeting in Washington, D.C.
The Dec. 5 open forum discussion of pre-purchase exams at sales at the American Association of Equine Practitioners convention in Denver covered several topics critical to consignors, buyers, and veterinarians.
The American Association of Equine Practitioners is celebrating its golden anniversary in 2004, and will hold its 50th annual convention in Denver, Colo., Dec. 4-8. The AAEP was founded in December 1954, in Louisville, Ky., by 11 charter members and now boasts approximately 8,000 members in 57 countries. Based on past conference attendance averages, some 2,700 veterinarians, veterinary students, and technicians will be there, while guests and exhibitors in the trade show that accompanies the conference will bring the grand total to about 5,500.
Hurricane preparation, toleration, and clean-up--take four. Horse owners and veterinarians in Florida weathered Category 3 Hurricane Jeanne beginning late Saturday, their fourth natural disaster in six weeks.
By Dr. Tom R. Lenz -- Federal legislation to ban the slaughter of horses in the United States for human consumption has become an emotional issue on which some groups within the equine industry can't see eye to eye. Here are the facts regarding the American Association of Equine Practitioners' position on H.R. 857, the American Horse Slaughter Prevention Act.
The American Association of Equine Practitioners (AAEP) is seeking proposals to research the efficacy of adjunct bleeder medications, such as aminocaproic acid and/or conjugated estrogens, as a race day medication for prevention of exercise-induced pulmonary hemorrhage (EIPH).
The American Quarter Horse Association, which has hundreds of thousands of members, has reiterated its position on euthanasia and horse slaughter in the wake of an accusatory Blue Horse Charities letter that was disseminated to the racing industry in early November.
Blue Horse Charities has stepped up the campaign for passage of legislation to ban horse slaughter with a strongly worded letter and a full-page advertisement on the back page of the Nov. 8 edition of Daily Racing Form.
Ray Paulick, editor in chief of The Blood-Horse and executive vice president and editorial director of Blood-Horse Publications, has been selected as the American Association of Equine Practitioners' (AAEP) equine industry representative on the group's board of directors.
Is there a horse doctor in the house? If the job trend for veterinary school graduates continues as it has for the past few years, then the answer might be "no."
As Funny Cide continues in his pursuit of the Triple Crown, it is bringing to the fore the question of why some horses are gelded and others are not. Dr. Larry Bramlage, on-call veterinarian for the American Association of Equine Practitioners, sheds light on the subject.
The American Association of Equine Practitioners (AAEP) issued a statement in early March about its stance regarding genetic defects and their treatment.
Racing and breeding news and information.
California's Dr. Jack Robbins shared some of his favorite memories and sounded off on current medication policy as the honor guest of the Thoroughbred Club of America's 71st annual Testimonial Dinner, held Friday evening at Keeneland.
Dr. Jack K. Robbins, instrumental in many aspects of racing and veterinary science in California for a half-century, has been named honor guest of the Thoroughbred Club of America's annual Testimonial Dinner.
- By Ray Paulick
By Ray Paulick -- Major League Baseball is trying to come to grips with a growing drug scandal involving anabolic steroids that some people feel already has tarnished some of the sport's most sacred records. It's one scandal that, for now, racing has managed to avoid.
The board of directors of the Kentucky Thoroughbred Association has formally stated its "dissatisfaction" with current medication policies in the Bluegrass State.
As the Racing Medication and Testing Consortium continues its march toward uniformity in Thoroughbred racing, battle lines are being formed by other groups that believe a furosemide-only policy on race days is too extreme.
The American Association of Equine Practitioners created the On-Call program 11 years ago to assist media in understanding injuries and treatment of horses before, during, and after upper-echelon equine events. For this year's Kentucky Derby, the team is headed by Dr. Larry Bramlage.
The newly christened Racing Medication and Testing Consortium said May 1 it has formed three task forces to focus on developing an organizational and business plan, scientific research priorities, and a model medication policy.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared for its March 12 meeting, some racetrack veterinarians moved closer to forming their own organization.
Representatives from about 20 industry organizations unanimously endorsed a plan to develop a national medication policy during a teleconference Jan. 28. The action followed the first Racehorse Medication Summit, held Dec. 4, 2001, in Tucson, Ariz.
The board of the National Horsemen's Benevolent and Protective Association, during its winter convention in Las Vegas, Nev., Jan. 22-24, passed two motions tied to medication issues: One calls for more representation in follow-up meetings to the Racehorse Medication Summit, while the other seeks official positions from affiliates on use of race-day therapeutic medication.
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Three industry officials gave their views Thursday night on issues they expect will figure prominently in 2002. It came as no surprise the issues are medication, economics, and legislation.
The official report on the Dec. 4 Racehorse Medication Summit organized by the American Association of Equine Practitioners could be released Jan. 4. The document is expected to provide information on consensus reached by the more than 30 industry officials who participated.
California is on board with a nationwide push for a consensus on racehorse medication, the president of the Thoroughbred Owners of California reported to his board the week of Dec. 10. But the TOC does have its own opinions on some of the specifics.
The second round of "super-test" results from the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force should be released early in January, said Jim Gallagher, executive director of the task force.
In the aftermath of Tuesday's Racehorse Medication Summit, it was all about time and money. Participants said they wouldn't have much more to say until the official minutes of the meeting are released, and that the success of any proposal hinges on a funding mechanism.
Participants at Tuesday's Racehorse Medication Summit in Tucson, Ariz., reached a consensus on medication, drug-testing, security, and enforcement, but said much of any future policy depends on scientific determinations. The group of about 30 industry officials did agree on the need for a uniform medication policy and decision levels for therapeutic medications, but specifics weren't discussed.
Racing industry participants expressed hope Tuesday morning that a five-hour facilitated session on medication would at least serve as a starting point toward uniformity. No one expected radical changes in current policies that vary by jurisdiction in the United States.
By Dr. C. Wayne McIlwraith -- The industry wants horse racing to increase in popularity and achieve the status of a major league sport. The time is right for us all to come together and reach consensus on medication issues.
The American Association of Equine Practitioners has spent many hours over the past year getting ready for the Dec. 4 medication summit that will be part of the University of Arizona Race Track Industry Program's Symposium on Racing. "We hope for the first time to bring together key stakeholders in the racing industry to specifically discuss racehorse medication," said Dr. Wayne McIlwraith, 2001 president of the AAEP.
Officials with the American Association of Equine Practitioners acknowledge that their "Racehorse Medication Summit" planned for Dec. 4 appears to have moved some organizations to action. But they admit the complex issue of medication and drug-testing can't be addressed in one day.
A wide-ranging group of industry representatives will take part in the Racehourse Medication Summit during the University of Arizona Race Track Industry Program's Annual Symposium on Racing. The medication summit, sponsored by the American Association of Equine Practitioners (AAEP), is planned for Dec. 4.
More than 2,5000 practitioners are expected for the 47th American Association of Equine Practitioners annual convention Nov. 24-28 in San Diego, Calif.
The American Association of Equine Practitioners has formed a task force to identify therapeutic medications used in racehorses. The organization was approached by the Testing Integrity Program, commonly known as TIP.
Most Popular Stories
- Luck of the Kitten Starts '15 in Transylvania
- U.S. Alleges Conspiracy at Penn National
- Is Mubtaahij a Major Derby Contender?
- El Kabeir Fires Bullet Work at Belmont
- Keeneland Plans Wide Live Broadcast Coverage
- Sherman: Ascot Could Be Rough on 'Chrome'
- Terranovas Seek Derby Success With El Kabeir
- Graham, Amoss, Moss Take FG Meet Titles
- Untapable Heads Asmussen Workers at Oaklawn
- Roodle & Riddle, EquiMarker Analytics Partner